Geron RYTELO FDA Approval Conference Call 2024

Geron held a conference call on June 7, 2024, to discuss the FDA approval of RYTELO (imetelstat), covering prescribing information, U.S. market opportunity, and commercial launch plans. The presentation outlines therapeutic and commercial potential, expected market dynamics, launch timing, and key success factors for RYTELO's market entry.